Midstate Radiology Associates, LLC introduces ProFound AI™, the first FDA-cleared 3D mammography software using artificial intelligence! Breast cancer screening has improved significantly in recent years with the advent of 3D mammography, or digital breast tomosynthesis (DBT).
While traditional 2D mammography typically yields four images per patient, 3D mammography produces hundreds of images per patient, providing doctors with more information and better images than ever before. DBT helps doctors find cancers earlier, when they may be more easily treated, with fewer false positives, which can be stressful for patients.
Our facility recently adopted new technology that further maximizes the benefits DBT offers to women. ProFound AI™ for DBT is the first FDA-cleared 3D tomosynthesis software using artificial intelligence (AI). The technology is FDA-cleared and clinically proven to enhance breast cancer detection, while significantly reducing the rate of false positives and unnecessary recalls for women.
“We are laser focused on adopting the latest and most innovative technologies at our imaging facilities, and iCAD’s comprehensive solutions fit nicely into our intense focus on preventative care, so we decided to adopt ProFound AI and PowerLook Density Assessment in 2020. With this technology, our density assessments have become more standardized and uniform, which has more than doubled our utilization of screening breast ultrasound and ultimately helps us identify which women would benefit from supplemental screening. Our team is overall more confident and efficient in reading even the most complex mammography cases.”
Tom Cappas
Chief Operating Officer (COO), MRA
How Does ProFound AI Work?
ProFound AI for DBT acts as another pair of eyes for radiologists reviewing 3D mammography images. Built with the latest in artificial intelligence, it rapidly and accurately analyzes each 3D mammogram image, detecting cancers with unrivaled accuracy. It provides crucial information to your doctor and alerts them if suspicious areas may warrant a closer look.
ProFound AI for DBT is FDA-cleared and clinically proven in a large reader study to improve cancer detection by 8% and reduce the rate of false positives and unnecessary recalls for women by 7%.*
Frequently Asked Questions
1. What is digital breast tomosynthesis (DBT) or 3D mammography?
3D mammography is a breast cancer screening test that captures hundreds of images of each breast per patient, offering improved image quality and more information than traditional 2D mammography, which typically only generates four images per patient. 3D mammography offers women a number of benefits compared to 2D mammography, including improved cancer detection, with fewer false positives and unnecessary recalls, which can be stressful for patients.
2. What is artificial intelligence?
Artificial intelligence (AI) is an advanced form of computer science that allows computers to learn and work like humans. AI is used in healthcare to help doctors review large amounts of data more quickly and accurately.
3. What is ProFound AI?
ProFound AI is the first FDA-cleared 3D tomosynthesis software using AI. It rapidly and accurately analyzes each 3D mammogram image, detecting cancers with unrivaled accuracy and alerting radiologists if suspicious areas may warrant a closer look.
4. Why is ProFound AI built on artificial intelligence?
AI enables ProFound AI to rapidly and accurately analyze each 3D mammogram image, detecting cancers with unrivaled accuracy. Trained with one of the largest available 3D mammography datasets, ProFound AI rapidly compares your mammography images against those it has learned from and alerts radiologists if suspicious areas may warrant a
closer look.
5. How does this technology benefit women?
ProFound AI further maximizes the benefits 3D mammography offers to women. It acts as another pair of eyes for doctors and is clinically proven to improve cancer detection by 8%, while reducing false positives by 7%, compared to 3D mammography alone.*
*Conant, E. et al. (2019). Improving Accuracy and Efficiency with Concurrent Use of Artificial Intelligence for Digital Breast Tomosynthesis. Radiology: Artificial Intelligence. 1 (4). Accessed viahttps://pubs.rsna.org/doi/10.1148/ryai.2019180096